C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TFPI2 mRNA" | 23146750 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of TFPI2 mRNA" | 23146750 |
C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of TFPI2 mRNA" | 16192472 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of TFPI2 mRNA | 21420995|2906747 |
D000082 | Acetaminophen | Acetaminophen affects the expression of TFPI2 mRNA | 17562736 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of TFPI2 mRNA | 11264010 |
D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA | 17585979 |
D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA] | 17585979 |
D020106 | Acrylamide | Acrylamide results in increased expression of TFPI2 mRNA | 28959563 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of TFPI2 protein | 20106945 |
D000393 | Air Pollutants | Air Pollutants analog results in increased expression of TFPI2 mRNA | 21757418 |
C025154 | alpha-cobratoxin | alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] | 12588870 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of TFPI2 mRNA | 16483693 |
C015001 | arsenite | arsenite results in decreased expression of TFPI2 mRNA | 23974009 |
D017636 | Asbestos, Amphibole | "Asbestos, Amphibole results in increased expression of TFPI2 mRNA" | 20831825 |
D017636 | Asbestos, Amphibole | "Asbestos, Amphibole results in increased expression of TFPI2 mRNA" | 22352330 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite affects the expression of TFPI2 mRNA" | 25757056 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of TFPI2 mRNA" | 18687144|2083182 |
C030935 | benz(a)anthracene | benz(a)anthracene results in decreased expression of TFPI2 mRNA | 26377693 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of TFPI2 mRNA | 17879257|2187194 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in increased expression of TFPI2 mRNA | 20660070 |
D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TFPI2 mRNA | 19619570 |
D004958 | Estradiol | Estradiol results in increased expression of TFPI2 mRNA | 16202921|1961957 |
C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA | 28628672 |
C006780 | bisphenol A | bisphenol A results in increased expression of TFPI2 mRNA | 19371625 |
C006780 | bisphenol A | bisphenol A results in increased methylation of TFPI2 gene | 28582417 |
C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TFPI2 mRNA | 28628672 |
C006780 | bisphenol A | bisphenol A affects the expression of TFPI2 mRNA | 25181051 |
C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TFPI2 mRNA | 28628672 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TFPI2 mRNA | 20147733|2207961 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA | 15336504 |
D002220 | Carbamazepine | Carbamazepine affects the expression of TFPI2 mRNA | 25979313 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of TFPI2 mRNA | 17484886 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of TFPI2 mRNA | 27339419 |
D002330 | Carmustine | TFPI2 mRNA affects the susceptibility to Carmustine | 16365179 |
D002737 | Chloroprene | Chloroprene results in decreased expression of TFPI2 mRNA | 23125180 |
D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA | 17585979 |
D002994 | Clofibrate | Clofibrate results in increased expression of TFPI2 mRNA | 17585979 |
D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA] | 17585979 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of TFPI2 mRNA | 19320972|1937684 |
D003078 | Colchicine | Colchicine results in increased expression of TFPI2 mRNA | 20624997 |
D003300 | Copper | Copper results in decreased expression of TFPI2 mRNA | 19747488 |
D019327 | Copper Sulfate | Copper Sulfate affects the expression of TFPI2 mRNA | 19549813 |
C402665 | CP 31398 | CP 31398 results in increased expression of TFPI2 mRNA | 15155752 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of TFPI2 mRNA | 20106945 |
C014347 | decitabine | [decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter | 17464989 |
C014347 | decitabine | [[decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter] which affects the expression of TFPI2 mRNA | 17464989|1746498 |
C014347 | decitabine | decitabine results in decreased methylation of TFPI2 promoter | 19435926 |
C014347 | decitabine | decitabine results in increased expression of TFPI2 mRNA | 19435926 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of TFPI2 mRNA | 25047013 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA | 28628672 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TFPI2 mRNA | 28628672 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TFPI2 mRNA | 28628672 |
C041517 | dibenzo(a,l)pyrene | "dibenzo(a,l)pyrene results in increased expression of TFPI2 mRNA" | 15735009 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of TFPI2 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in decreased expression of TFPI2 mRNA | 27392435 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of TFPI2 mRNA | 28085963 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of TFPI2 mRNA | 19850644 |
D004051 | Diethylhexyl Phthalate | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TFPI2 mRNA] | 19850644 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of TFPI2 mRNA | 25380136 |
D004317 | Doxorubicin | TFPI2 protein affects the susceptibility to Doxorubicin | 16217747 |
D052244 | Endocrine Disruptors | Endocrine Disruptors results in decreased expression of TFPI2 mRNA | 25198161 |
D004726 | Endosulfan | Endosulfan results in increased expression of TFPI2 mRNA | 26615145 |
C118739 | entinostat | entinostat results in increased expression of TFPI2 mRNA | 26272509 |
C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
D005047 | Etoposide | TFPI2 protein affects the susceptibility to Etoposide | 16217747 |
D004397 | Fonofos | Fonofos results in increased methylation of TFPI2 promoter | 22847954 |
C039281 | furan | furan results in increased expression of TFPI2 mRNA | 27387713 |
C010974 | glyphosate | glyphosate results in increased expression of TFPI2 mRNA | 25636363 |
D017313 | Fenretinide | Fenretinide results in increased expression of TFPI2 mRNA | 28973697 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA | 28628672 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TFPI2 mRNA | 28628672 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TFPI2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TFPI2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TFPI2 mRNA | 28628672 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of TFPI2 mRNA | 27392435 |
C544151 | jinfukang | jinfukang results in decreased expression of TFPI2 mRNA | 27392435 |
D008154 | Lucanthone | Lucanthone results in increased expression of TFPI2 mRNA | 21148553 |
C015329 | lycopene | lycopene results in decreased expression of TFPI2 mRNA | 16886892 |
D008464 | Mecamylamine | Mecamylamine inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] | 12588870 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in decreased expression of TFPI2 mRNA | 20843944 |
D008558 | Melphalan | Melphalan results in increased expression of TFPI2 mRNA | 22363485 |
C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
D008727 | Methotrexate | Methotrexate affects the expression of TFPI2 mRNA | 18502557 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of TFPI2 mRNA | 28001369 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of TFPI2 mRNA | 26011545 |
D016685 | Mitomycin | TFPI2 protein affects the susceptibility to Mitomycin | 16217747 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of TFPI2 mRNA" | 25620056 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of TFPI2 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of TFPI2 mRNA" | 25554681|2562005 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of TFPI2 mRNA | 25380136 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of TFPI2 mRNA | 22714537 |
D009538 | Nicotine | alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] | 12588870 |
D009538 | Nicotine | Mecamylamine inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] | 12588870 |
D009538 | Nicotine | Nicotine results in decreased expression of TFPI2 mRNA | 12588870 |
D009538 | Nicotine | Nicotine results in increased expression of TFPI2 mRNA | 12588870 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of TFPI2 mRNA | 25729387 |
C030110 | oxaliplatin | oxaliplatin results in increased expression of TFPI2 mRNA | 25729387 |
D010126 | Ozone | [Ozone co-treated with NOTCH3 gene mutant form] affects the expression of TFPI2 mRNA | 25658374 |
D010126 | Ozone | [Ozone co-treated with NOTCH4 gene mutant form] affects the expression of TFPI2 mRNA | 25658374 |
D010126 | Ozone | Ozone results in decreased expression of TFPI2 mRNA | 16183385 |
D010126 | Ozone | Ozone results in decreased expression of TFPI2 protein | 16183385 |
D017239 | Paclitaxel | TFPI2 protein affects the susceptibility to Paclitaxel | 16217747 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C496932 | panobinostat | panobinostat results in increased expression of TFPI2 mRNA | 26272509 |
D010278 | Parathion | Parathion results in increased methylation of TFPI2 promoter | 22847954 |
C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of TFPI2 mRNA | 26705709 |
D010634 | Phenobarbital | Phenobarbital affects the expression of TFPI2 mRNA | 19159669 |
D010634 | Phenobarbital | Phenobarbital affects the expression of TFPI2 mRNA | 19136022 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of TFPI2 mRNA | 26272509 |
C006253 | pirinixic acid | pirinixic acid affects the expression of TFPI2 mRNA | 19136022 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of TFPI2 mRNA | 18445702 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of TFPI2 mRNA | 17426115|1830175 |
C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of TFPI2 mRNA] | 20059764 |
D011239 | Prednisolone | Prednisolone results in decreased expression of TFPI2 mRNA | 17379860 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in increased expression of TFPI2 mRNA | 20660070 |
D011374 | Progesterone | Progesterone results in increased expression of TFPI2 mRNA | 21795739 |
D011794 | Quercetin | Quercetin results in increased expression of TFPI2 mRNA | 21632981 |
D011794 | Quercetin | Quercetin affects the expression of TFPI2 mRNA | 18178720 |
C059514 | resveratrol | resveratrol results in increased expression of TFPI2 mRNA | 19371625|2588880 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of TFPI2 mRNA" | 24160326 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of TFPI2 mRNA | 25895662 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of TFPI2 mRNA | 25351596 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of TFPI2 mRNA | 22714537 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of TFPI2 mRNA | 16014739 |
C047246 | temozolomide | TFPI2 mRNA affects the susceptibility to temozolomide | 16365179 |
C012568 | terbufos | terbufos results in increased methylation of TFPI2 promoter | 22847954 |
C501413 | tesaglitazar | tesaglitazar results in increased expression of TFPI2 mRNA | 21515302 |
D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TFPI2 mRNA | 19619570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of TFPI2 mRNA | 19619570 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of TFPI2 mRNA | 28065790 |
D019772 | Topotecan | TFPI2 protein affects the susceptibility to Topotecan | 16217747 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of TFPI2 mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in increased expression of TFPI2 mRNA | 25729387 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of TFPI2 mRNA" | 19682533 |
D014212 | Tretinoin | Tretinoin results in decreased expression of TFPI2 mRNA | 23724009 |
D014212 | Tretinoin | Tretinoin results in increased expression of TFPI2 mRNA | 21934132|2383079 |
C012589 | trichostatin A | [decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter | 17464989 |
C012589 | trichostatin A | [[decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter] which affects the expression of TFPI2 mRNA | 17464989|1746498 |
C012589 | trichostatin A | trichostatin A results in increased expression of TFPI2 mRNA | 24935251|2627250 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of TFPI2 mRNA" | 26743178 |
D014520 | Urethane | Urethane results in increased expression of TFPI2 mRNA | 28818685 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of TFPI2 mRNA | 23179753|2438349 |
D014635 | Valproic Acid | Valproic Acid affects the expression of TFPI2 mRNA | 17292431 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of TFPI2 gene | 25560391 |
D014747 | Vinblastine | TFPI2 protein affects the susceptibility to Vinblastine | 16217747 |
D014747 | Vinblastine | Vinblastine results in increased expression of TFPI2 mRNA | 20624997 |
C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of TFPI2 mRNA | 26682919 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA" | 27188386 |
C111237 | vorinostat | vorinostat results in increased expression of TFPI2 mRNA | 26272509 |
D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in decreased expression of TFPI2 mRNA" | 25198161 |
D015032 | Zinc | Zinc results in increased expression of TFPI2 mRNA | 16870260 |
C016837 | zinc chloride | zinc chloride results in increased expression of TFPI2 mRNA | 16870260 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of TFPI2 mRNA | 24714768 |